HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

cupric acetate (copper(II) acetate)

Also Known As:

copper(II) acetate; Cu(II) acetate; copper(I) acetate; copper(II) acetate monohydrate; hoganite

Networked: 10 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organometallic Compounds: 64
  - cupric acetate: 10

Experts

1.	Gröger, Harald: 1 article (01/2022)
2.	Nonnhoff, Jannis: 1 article (01/2022)
3.	Guevara, Patricia: 1 article (01/2013)
4.	Gómez, Esteban: 1 article (01/2013)
5.	Lopez, Tessy: 1 article (01/2013)
6.	Ortiz-Islas, Emma: 1 article (01/2013)
7.	Agrawal, S S: 1 article (04/2011)
8.	Jose, M Alvin: 1 article (04/2011)

Related Diseases

1.	Carcinogenesis 12/01/1984 - "This result suggests that sc injection of cupric acetate may have a suppressive effect on the initiation of carcinogenesis in the liver." 04/01/1976 - "Mechanism of suppressive effect of basic cupric acetate on rat liver carcinogenesis by ethionine." 11/01/1975 - "The addition of cupric acetate, a potent inhibitor of ethionine carcinogenesis, to a diet containing ethionine increased the ethionine toxicity. " 12/01/1984 - "Suppressive effect of cupric acetate on DNA alkylation, DNA synthesis and tumorigenesis in the liver of dimethylnitrosamine-treated rats."
2.	Neoplasms (Cancer) 12/01/1984 - "No tumor was observed in the group given saline or cupric acetate alone. " 12/01/1984 - "The incidence of liver tumors in rats given DMN and cupric acetate was thus only about 40% of that in rats given DMN alone. " 12/01/1984 - "In the group given DMN and cupric acetate (sc injections of 2 mg of Cu/kg of body weight once a week for 26 weeks), 7 of 22 rats developed liver tumors. " 01/01/2013 - "The anticancer properties of pure copper (II) acetate and copper (II) acetylacetonate, alone and loaded on functionalized sol-gel titania (TiO(2)), were determined in four different cancer cell lines (C6, RG2, B16, and U373), using increasing concentrations of these compounds. "
3.	Body Weight (Weight, Body) 04/01/2011 - "Thirty minutes after the administration of the last dose, a freshly prepared 0.4 % solution of cupric acetate was administered to each animal intravenously via the marginal ear vein (4 mg/kg body weight) to induce ovulation. " 12/01/1984 - "In the group given DMN and cupric acetate (sc injections of 2 mg of Cu/kg of body weight once a week for 26 weeks), 7 of 22 rats developed liver tumors. "
4.	Tachypnea 10/31/1985 - "The lecithin/sphingomyelin ratios, determined with either cupric acetate or phosphomolybdate as the detection reagent, are compared for their abilities to predict respiratory distress syndrome (RDS), transient tachypnea (TTN), or the absence of respiratory difficulty in neonates. "
5.	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/31/1985 - "The lecithin/sphingomyelin ratios, determined with either cupric acetate or phosphomolybdate as the detection reagent, are compared for their abilities to predict respiratory distress syndrome (RDS), transient tachypnea (TTN), or the absence of respiratory difficulty in neonates. "

Related Drugs and Biologics

1.	Ethionine
2.	Lecithins
3.	Polymethyl Methacrylate (Sol)
4.	Sphingomyelins
5.	Solutions
6.	Oximes
7.	Nitriles
8.	Ligands
9.	Indicators and Reagents (Reagents)
10.	DNA (Deoxyribonucleic Acid)

Related Therapies and Procedures

1.	Injections